What is the price of GILD if they do 4 billion in Sovaldi this year? 5 billion? A lot higher than 80 bucks... I can tell you that. And, it's almost a foregone conclusion that they will.
Big volume today. Somebody getting in, and somebody getting out. Let's hope the guy getting in is smarter.
Man, we need some news.
I'm long, and I'm glad CYTK is up, but let's keep things in perspective. 6 months ago, we were at $14. Still a lot of wood to chop here. With all these partnerships, how about banking a milestone payment?
They put everything they could into expense guidance, SG&A and R&D, including all the launch expenses for Sovaldi and Idelasib. But no revs for either product. This is a huge skew towards conservatism, if not flat out sandbagging. Heck, they even included Sovaldi discounts in Europe as SG&A expenses.
Deutsche raised before GILD reports next week to get the jump on the other analysts who are waiting for the report. Numbers are going to be going up across the board next Wednesday. Buckle up.